Presart

Adults:

Dosage should be tailored to each patient. The usual starting dose of Telmisartan tablets is 40 mg once daily. Blood pressure response is dose related across the range of 20 to 80 mg. Most of the antihypertensive effect shows up within 2 weeks, and the maximal reduction is generally reached after 4 weeks. If additional blood pressure lowering is needed beyond what 80 mg of Telmisartan provides, a switch to combination therapy may be considered. No initial dosage adjustment is needed for elderly patients or for patients with renal impairment, including those on hemodialysis. Patients on dialysis may develop orthostatic hypotension, so their blood pressure should be monitored closely. Telmisartan tablets may be given together with other antihypertensive agents, and may be taken with or without food. Starting Telmisartan therapy is not recommended in patients aged 75 years or older or in those with hepatic impairment. Pediatric use: the safety and effectiveness of Telmisartan in pediatric patients have not been established. Geriatric use: no overall differences in effectiveness and safety were seen in these patients compared with younger patients. Hepatic impairment: monitor carefully and increase the dose slowly in patients with biliary obstructive disorders or hepatic insufficiency.